The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.
Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.
The global Soliris market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Soliris volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Soliris market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Soliris Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Alexion
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.
Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.
The global Soliris market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Soliris volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Soliris market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Soliris Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Alexion
Index1 Soliris Market Overview
1.1 Product Overview and Scope of Soliris
1.2 Soliris Segment by Type
1.2.1 Global Soliris Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Soliris Segment by Application
1.3.1 Global Soliris Sales Comparison by Application: (2021-2027)
1.3.2 PNH
1.3.3 aHUS
1.3.4 Other
1.4 Global Soliris Market Size Estimates and Forecasts
1.4.1 Global Soliris Revenue 2016-2027
1.4.2 Global Soliris Sales 2016-2027
1.4.3 Soliris Market Size by Region: 2016 Versus 2021 Versus 2027
2 Soliris Market Competition by Manufacturers
2.1 Global Soliris Sales Market Share by Manufacturers (2016-2021)
2.2 Global Soliris Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Soliris Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Soliris Manufacturing Sites, Area Served, Product Type
2.5 Soliris Market Competitive Situation and Trends
2.5.1 Soliris Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Soliris Players Market Share by Revenue
2.5.3 Global Soliris Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Soliris Retrospective Market Scenario by Region
3.1 Global Soliris Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Soliris Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Soliris Market Facts & Figures by Country
3.3.1 North America Soliris Sales by Country
3.3.2 North America Soliris Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Soliris Market Facts & Figures by Country
3.4.1 Europe Soliris Sales by Country
3.4.2 Europe Soliris Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Soliris Market Facts & Figures by Region
3.5.1 Asia Pacific Soliris Sales by Region
3.5.2 Asia Pacific Soliris Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Soliris Market Facts & Figures by Country
3.6.1 Latin America Soliris Sales by Country
3.6.2 Latin America Soliris Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Soliris Market Facts & Figures by Country
3.7.1 Middle East and Africa Soliris Sales by Country
3.7.2 Middle East and Africa Soliris Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Soliris Historic Market Analysis by Type
4.1 Global Soliris Sales Market Share by Type (2016-2021)
4.2 Global Soliris Revenue Market Share by Type (2016-2021)
4.3 Global Soliris Price by Type (2016-2021)
5 Global Soliris Historic Market Analysis by Application
5.1 Global Soliris Sales Market Share by Application (2016-2021)
5.2 Global Soliris Revenue Market Share by Application (2016-2021)
5.3 Global Soliris Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Alexion
6.1.1 Alexion Corporation Information
6.1.2 Alexion Description and Business Overview
6.1.3 Alexion Soliris Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Alexion Soliris Product Portfolio
6.1.5 Alexion Recent Developments/Updates
7 Soliris Manufacturing Cost Analysis
7.1 Soliris Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Soliris
7.4 Soliris Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Soliris Distributors List
8.3 Soliris Customers
9 Soliris Market Dynamics
9.1 Soliris Industry Trends
9.2 Soliris Growth Drivers
9.3 Soliris Market Challenges
9.4 Soliris Market Restraints
10 Global Market Forecast
10.1 Soliris Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Soliris by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Soliris by Type (2022-2027)
10.2 Soliris Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Soliris by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Soliris by Application (2022-2027)
10.3 Soliris Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Soliris by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Soliris by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Soliris Sales (Unit) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Soliris Sales (Unit) Comparison by Application (2021-2027)
Table 3. Global Soliris Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Soliris Covered in This Study
Table 5. Global Soliris Sales (Unit) of Key Manufacturers (2016-2021)
Table 6. Global Soliris Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Soliris Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Soliris Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Soliris Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Soliris Manufacturing Sites and Area Served
Table 11. Manufacturers Soliris Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Soliris by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soliris as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Soliris Sales by Region (2016-2021) & (Unit)
Table 16. Global Soliris Sales Market Share by Region (2016-2021)
Table 17. Global Soliris Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Soliris Sales by Country (2016-2021) & (Unit)
Table 19. North America Soliris Sales Market Share by Country (2016-2021)
Table 20. North America Soliris Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Soliris Revenue Market Share by Country (2016-2021)
Table 22. Europe Soliris Sales by Country (2016-2021) & (Unit)
Table 23. Europe Soliris Sales Market Share by Country (2016-2021)
Table 24. Europe Soliris Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Soliris Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Soliris Sales by Region (2016-2021) & (Unit)
Table 27. Asia Pacific Soliris Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Soliris Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Soliris Revenue Market Share by Region (2016-2021)
Table 30. Latin America Soliris Sales by Country (2016-2021) & (Unit)
Table 31. Latin America Soliris Sales Market Share by Country (2016-2021)
Table 32. Latin America Soliris Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Soliris Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Soliris Sales by Country (2016-2021) & (Unit)
Table 35. Middle East and Africa Soliris Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Soliris Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Soliris Revenue Market Share by Country (2016-2021)
Table 38. Global Soliris Sales (Unit) by Type (2016-2021)
Table 39. Global Soliris Sales Market Share by Type (2016-2021)
Table 40. Global Soliris Revenue (Million US$) by Type (2016-2021)
Table 41. Global Soliris Revenue Share by Type (2016-2021)
Table 42. Global Soliris Price (US$/Unit) by Type (2016-2021)
Table 43. Global Soliris Sales (Unit) by Application (2016-2021)
Table 44. Global Soliris Sales Market Share by Application (2016-2021)
Table 45. Global Soliris Revenue (Million US$) by Application (2016-2021)
Table 46. Global Soliris Revenue Share by Application (2016-2021)
Table 47. Global Soliris Price (US$/Unit) by Application (2016-2021)
Table 48. Alexion Corporation Information
Table 49. Alexion Description and Business Overview
Table 50. Alexion Soliris Sales (Unit), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Alexion Soliris Product
Table 52. Alexion Recent Developments/Updates
Table 53. Production Base and Market Concentration Rate of Raw Material
Table 54. Key Suppliers of Raw Materials
Table 55. Soliris Distributors List
Table 56. Soliris Customers List
Table 57. Soliris Market Trends
Table 58. Soliris Growth Drivers
Table 59. Soliris Market Challenges
Table 60. Soliris Market Restraints
Table 61. Global Soliris Sales Forecast by Type (2022-2027) & (Unit)
Table 62. Global Soliris Sales Market Share Forecast by Type (2022-2027)
Table 63. Global Soliris Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 64. Global Soliris Revenue Market Share Forecast by Type (2022-2027)
Table 65. Global Soliris Sales Forecast by Application (2022-2027) & (Unit)
Table 66. Global Soliris Sales Market Share Forecast by Application (2022-2027)
Table 67. Global Soliris Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 68. Global Soliris Revenue Market Share Forecast by Application (2022-2027)
Table 69. Global Soliris Sales Forecast by Region (2022-2027) & (Unit)
Table 70. Global Soliris Sales Market Share Forecast by Region (2022-2027)
Table 71. Global Soliris Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 72. Global Soliris Revenue Market Share Forecast by Region (2022-2027)
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Soliris
Figure 2. Global Soliris Market Share by Type in 2020 & 2027
Figure 3. Plasma Exchange Product Picture
Figure 4. Plasma Infusion Product Picture
Figure 5. Global Soliris Market Share by Application in 2020 & 2027
Figure 6. PNH
Figure 7. aHUS
Figure 8. Other
Figure 9. Global Soliris Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Soliris Market Size 2016-2027 (US$ Million)
Figure 11. Global Soliris Sales 2016-2027 (Unit)
Figure 12. Global Soliris Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Soliris Sales Share by Manufacturers in 2020
Figure 14. Global Soliris Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Soliris Players: Market Share by Revenue in 2020
Figure 16. Soliris Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Soliris Sales Market Share by Region (2016-2021)
Figure 18. Global Soliris Sales Market Share by Region in 2020
Figure 19. Global Soliris Revenue Market Share by Region (2016-2021)
Figure 20. Global Soliris Revenue Market Share by Region in 2020
Figure 21. U.S. Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Soliris Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Soliris by Type (2016-2021)
Figure 46. Sales Market Share of Soliris by Application (2016-2021)
Figure 47. Sales Market Share of Soliris by Application in 2020
Figure 48. Revenue Share of Soliris by Application (2016-2021)
Figure 49. Revenue Share of Soliris by Application in 2020
Figure 50. Manufacturing Cost Structure of Soliris
Figure 51. Manufacturing Process Analysis of Soliris
Figure 52. Soliris Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
